Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Frew

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
The British Journal of Dermatology|February 22, 2022
Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serumKristina Navrazhina, John W Frew, David Grand, et al.
Journal of the American Academy of Dermatology|August 25, 2009
A ski and adventure camp for young patients with severe forms of epidermolysis bullosaMary Alice Nading, Julien J Lahmar, John W Frew, et al.
Pigment Cell & Melanoma Research|September 30, 2023
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanomaKristina Navrazhina, Sandra Garcet, Samuel C Williams, et al.
Acta Dermato-Venereologica|December 17, 2013
Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch populationWing Yan Yuen, John W Frew, Kelly Veerman, et al.
The Australasian Journal of Dermatology|October 10, 2024
Quality-of-life evaluation in hidradenitis suppurativa in Australia: Validation and outcomes of the HiSQOL questionnaireKyle Wu, Conor Larney, Gill Marshman, et al.
Journal of the American Academy of Dermatology|December 11, 2012
Diffuse melanosis cutis: a systematic review of the literatureDeshan F Sebaratnam, Supriya S Venugopal, John W Frew, et al.
Experimental Dermatology|September 2, 2022
Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativaArtiene Tatian, Sara Bordbar, Samuel Der Sarkissian, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, AustraliaJames Pham, Akshay Flora, Emily Kay Kozera, et al.
Plos One|November 3, 2023
Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in vivoAkshay Flora, Rebecca Jepsen, Emily K Kozera, et al.
JAMA Dermatology|January 19, 2022
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic ReviewSamuel Der Sarkissian, Schapoor Hessam, Joslyn S Kirby, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The British Journal of Dermatology|February 22, 2022
Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serumKristina Navrazhina, John W Frew, David Grand, et al.
Journal of the American Academy of Dermatology|August 25, 2009
A ski and adventure camp for young patients with severe forms of epidermolysis bullosaMary Alice Nading, Julien J Lahmar, John W Frew, et al.
Pigment Cell & Melanoma Research|September 30, 2023
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanomaKristina Navrazhina, Sandra Garcet, Samuel C Williams, et al.
Acta Dermato-Venereologica|December 17, 2013
Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch populationWing Yan Yuen, John W Frew, Kelly Veerman, et al.
The Australasian Journal of Dermatology|October 10, 2024
Quality-of-life evaluation in hidradenitis suppurativa in Australia: Validation and outcomes of the HiSQOL questionnaireKyle Wu, Conor Larney, Gill Marshman, et al.
Journal of the American Academy of Dermatology|December 11, 2012
Diffuse melanosis cutis: a systematic review of the literatureDeshan F Sebaratnam, Supriya S Venugopal, John W Frew, et al.
Experimental Dermatology|September 2, 2022
Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativaArtiene Tatian, Sara Bordbar, Samuel Der Sarkissian, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, AustraliaJames Pham, Akshay Flora, Emily Kay Kozera, et al.
Plos One|November 3, 2023
Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in vivoAkshay Flora, Rebecca Jepsen, Emily K Kozera, et al.
JAMA Dermatology|January 19, 2022
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic ReviewSamuel Der Sarkissian, Schapoor Hessam, Joslyn S Kirby, et al.
Pageof 10